SBIR/STTR Research Award
A quantitative and real-time point-of-care multiplex immunoassay to monitor ART/PrEP medication adherence
Award amount
$306,100Program and phase
SBIR · Phase IAward year
2025Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- HIGH THROUGHPUT BIOLOGY INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- XJMFEHXLB9M5
- Solicitation number
- PHS 2025-1
- Topic code
- 3
Research abstract
A quantitative and real-time point-of-care multiplex immunoassay to monitor ART/PrEP medication adherence
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- FY23. SBIR TOPIC 167 PHASE I: AN ARRAY-BASED MULTIPLEX IMMUNOASSAY FOR POSTMORTEM TOXICOLOGY SCREENING
- A DNA-based Barcode System to Prevent Drug Counterfeiting
- A novel pattern-based framework for genetic analysis
- A novel pattern-based framework for genetic analysis
Research funding history
5 SBIR/STTR records share this UEI (2003–2025). Reported award amounts total $1,910,352. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services